Compare COA-verified suppliers in the PepPal supplier directory and verify current vial size, concentration, and lab testing before any sourcing decision
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
injected, essentially all of it reaches circulation
No clinic, no waiting room
In recent years, 5Amino1MQ Peptide (abbreviated as 5Amino1MQ), a highly selective smallmolecule peptide inhibitor targeting nicotinamide Nmethyltransferase (NNMT), has exhibited broad application prospects and become a research hotspot in obesity and adipose tissue research due to its unique mechanism, favorable targeting ability, and safety
Possible side effects are not well defined because no controlled human safety trial exists